Utility of the revised cardiac risk index for predicting postsurgical morbidity in Hb SC and Hb Sβ+-thalassemia sickle cell disease

Am J Hematol. 2016 Jun;91(6):E316-7. doi: 10.1002/ajh.24363. Epub 2016 Apr 24.

Authors

Affiliations

¹ Internal Medicine, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
² Comprehensive Sickle Cell Center, Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
³ Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois.
⁴ Jesse Brown VA Medical Center, Chicago, Illinois.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Adult
Aged
Anemia, Sickle Cell / mortality
Anemia, Sickle Cell / surgery*
Cardiovascular Diseases / etiology*
Female
Humans
Male
Middle Aged
Risk Factors
Survival Rate
Thalassemia / mortality
Thalassemia / surgery*
Young Adult

Grants and funding

K23 HL125984/HL/NHLBI NIH HHS/United States